ArticleBlood cancer journal2022

Therapy-related myeloid neoplasms following chimeric antigen receptor T-cell therapy for Non-Hodgkin Lymphoma.

Hassan B Alkhateeb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.